Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Börne- og juvenil absenceepilepsi. Behandling og prognose
Engelsk titel: Childhood and juvenile absence epilepsy. Treatment and prognosis Läs online Författare: Bisgaard Pedersen AM ; Rasmussen NH Språk: Dan Antal referenser: 30 Dokumenttyp: Översikt UI-nummer: 04111487

Tidskrift

Ugeskrift for Laeger 2004;166(46)4133-5 ISSN 0041-5782 E-ISSN 1603-6824 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

Childhood and juvenile absence epilepsy are epileptic syndrom in which the maín seizures are absences and which begins in children below and above 10 years of age, respectively. There is only one small randomized controlled study of treatment of childhood and juvenile absence epilepsy, and it shows evidence in category 1 for treatment with valproate and ethosuximide for a period of 12 weeks. There is also one »responder-enriched« study that shows evidence in category 2 for lamotrogine, while there is evidence in category 4 for several other antiepileptics. There is consensus for treatment with valproate, ethosuximide and lamotrigine. Several studies indicate a good seizure prognosis. A search of the literature did not reveal sufficient studies of the prognosis for cognitive and social development.